DTA Announces 2022 Task Groups and Co-Chairs
Engagement from industry leaders will provide critical support on executing DTA’s 2022 priorities
Tuesday, March 22, 2022 – Arlington, VA – This year, The Digital Therapeutics Alliance (DTA) is leading initiatives focused on three priorities — at the international, national, and regional levels — to drive the industry forward.
DTA members and Resource Partners are spearheading our efforts to transform global healthcare through seven newly launched Task Groups.
Asia Pacific Policy Task Group
Focus: This group focuses on key aspects of the Asia-Pacific policy landscape, including regulatory frameworks and national funding pathways.
DTA Member Co-Chairs:
- Roger Darlington, Business Development Manager at Mundipharma
- Sirius Baiyan Ge, Director of Digital Therapeutics Innovation at Weimai
- Danny Kim, Chief of Staff at WELT
Focus: This group is developing DTx-specific guidelines and core criteria for healthcare decision maker clinical evidence evaluation processes.
DTA Member Co-Chairs:
- Taehwa Han, Research Professor at Yonsei University Health System
- Vandana Menon, VP of Clinical Research and Evidence Generation at Akili Interactive
- Dario Motti, Global Principal Scientist Digital Health Technologies at Roche
- Jeanette Waxmonsky, Director of Research at Big Health
Resource Partners:
- Curebase
- Sidley Austin, LLP
DTx Value Assessment & Integration Guide Task Group
Focus: This group is guiding the launch and update phases of DTA’s ‘DTx Value Assessment & Integration Guide,’ which establishes a framework to consistently evaluate and benchmark DTx products.
DTA Member Co-Chairs:
- Taehwa Han, Research Professor at Yonsei University Health System
- Jeanette Waxmonsky, Director of Research at Big Health
Resource Partner:
- Sidley Austin, LLP
Focus: This group focuses on key aspects of the European policy landscape, including Health Technology Assessment (HTA) frameworks, national funding, and patient access pathways.
DTA Member Co-Chairs:
- Helene Moore, General Manager at Ethypharm Digital Therapy
- Mikaela Odlander, Director and Head of Digital Therapeutics at Orexo
Public Relations & Communications Task Group
Focus: This group is developing resources to promote broader DTx awareness and understanding, in addition to addressing industry-level challenges.
DTA Member Co-Chairs:
- Danny Kim, Chief of Staff at WELT
- Anni Mansikkaoja, Marketing & Communications Manager at Kaiku Health
- Jake Mazanke, Head of Communications at Big Health
- Lauren Steidl, Corporate Communications Lead at MedRhythms, Inc.
US Commercialization & Reimbursement Task Group
Focus: This group is working to establish payment pathways in the United States by addressing coding and coverage issues, in addition to developing product commercialization resources.
DTA Member Co-Chairs:
- Aaron Gani, Founder & CEO at BehaVR
- Joseph Perekupka, Representing MedRhythms
Resource Partners:
- ClearView Healthcare Partners
Focus: This group is focused on DTA’s ongoing work related to U.S. legislation and regulatory efforts with federal agencies.
DTA Member Co-Chairs:
- Michael Pace, Representing Woebot Health
- Will Robinson, Head of Policy and Strategy at Big Health
Resource Partners:
- Sidley
- Mason Street
As DTA continues to lead the digital therapeutic industry, these collective efforts will be instrumental in providing patients and caregivers, clinicians, policymakers, and healthcare decision makers with reliable resources to meaningfully integrate DTx products into practice to improve clinical and health economic outcomes globally.
About DTA
The Digital Therapeutics Alliance (DTA) is a global non-profit trade association of industry leaders and stakeholders with the mission of broadening the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. To learn more, please visit: www.dtxalliance.org or follow us on LinkedIn and Twitter.